Efficacy and Safety of Eculizumab in Enteroaggregative <i>E. coli</i> Associated Hemolytic Uremic Syndrome

Background. Hemolytic uremic syndrome (HUS) may present atypically without the full triad of classical HUS. Eculizumab has been shown to be efficacious in complement-mediated atypical HUS and some cases of Shiga-toxin (ST) associated HUS. We report the utility of eculizumab in enteroaggregative <i>E...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Ratna Acharya, William L. Clapp, Kiran Upadhyay
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	MDPI AG 2024-01-01
Edice:	Pediatric Reports
Témata:	hemolytic uremic syndrome eculizumab enteroaggregative <i>E. coli</i> children
On-line přístup:	https://www.mdpi.com/2036-7503/16/1/3
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!